Table 6—

Assessment of asthma control worsening(change in Asthma Control Questionnaire (ΔACQ) >+0.5)

Nonsmokers#Smokers#
TotalD ≤500D >500ACQ <2+ΔD 0§TotalD ≤500D >500ACQ <2+ΔD 0§
Total events n6433063374323019235575347
Positive cases n1616497130992611151714
Prevalence25212930332831263230
Sensitivity51674254486770647157
Specificity76767873707784918673
PPV37434447345278437147
NPV84907779808687858680
Accuracy70746867657486708168
p-valueƒ<0.001<0.001<0.001<0.001<0.001<0.001<0.0010.037<0.0010.025
  • Data are presented as %, unless otherwise indicated. PPV: positive predictive value; NPV: negative predictive value. #: cut-off value of +30%; : inhaled corticosteroid (ICS) dose (D) in μg equivalents of beclomethasone diproprionate·day−1; +: ACQ <2 tested the subgroup with an initial ACQ score <2; §: ΔD 0 tested the subgroup without treatment modification between consecutive visits; ƒ: the p-value is the statistical significance of rejecting an area under the curve of 0.5. A positive event is defined as a worsening of asthma control. A true-positive case was defined as an exhaled nitric oxide fraction (FeNO) change of more than or the same as the cut-off value associated with a worsening of asthma control between consecutive visits. When smoking patients were treated with a high ICS dose, FeNO ability to detect a worsening of control was somewhat reduced (p = 0.037).